# 变性女性患者荷尔蒙治疗后的乳房缩小

**来源**: Annals of Plastic Surgery  
**发布日期**: 2019-10-01  
**更新日期**: 2019-11-01  
**DOI**: [10.1097/sap.0000000000001855](https://doi.org/10.1097/sap.0000000000001855)  
**作者**: Ilana G Margulies, Hope Xu, Aki Kozato, Alexander Facque, Peter J Taub  
**所属机构**: 从医学与重建外科, 纽约西奈山医学学院, 纽约, NY.

在男女之间的性别过渡中，个人要求采取多种干预措施，包括激素疗法，以促进女性化特征。规定使用基于雌激素的药物来增加乳房发育，减少面部毛发，促进女性脂肪组织沉积并软化皮肤。对于这类跨性别患者，外科手术隆胸以补充荷尔蒙治疗后不满意的乳房生长是一种常见且经过充分研究的治疗方法。与常规不同的是，作者提出了一例有症状的巨大乳房病例，该患者需要在经过24年的激素治疗并在包括乳房在内的身体多个部位进行非法硅胶注射后，对变性女性进行手术性乳房缩小术。

![点击查看英文标题和摘要](https://scdn.x-mol.com/jcss/images/paperTranslation.png)

**Breast Reduction Following Hormonal Therapy in a Transgender Female Patient.** In male-to-female gender transition, individuals request a number of interventions, including hormonal therapy, to promote feminizing characteristics. Estrogen-based medication is prescribed to increase breast development, decrease facial hair, promote feminine adipose tissue deposition, and soften skin. Surgical breast augmentation to supplement unsatisfying breast growth after hormonal therapy is a common and well-studied course of management for such transgender patients. In a departure from convention, the authors present a case of symptomatic macromastia requiring surgical breast reduction in a transgender woman following 24 years of hormonal therapy and illicit silicone injections in multiple areas of her body, including the breasts.